scholarly journals Atrax Robustus Envenomation

1980 ◽  
Vol 8 (4) ◽  
pp. 410-420 ◽  
Author(s):  
M. McD. Fisher ◽  
G. A. Carr ◽  
R. McGuinness ◽  
J. C. Warden

Two patients who developed massive pulmonary oedema, profound vasoconstriction and hypertension followed by hypotension after Atrax Robustus envenomation are described. The pulmonary oedema is due to increased pulmonary capillary membrane permeability which may be due to neurogenic or toxic causes. Use of artificial ventilation with high level PEEP, isoprenaline and high dose steroids allowed support of the patients during volume replacement with albumin. When the circulation was stable and airway frothing ceased, conventional dehydration therapy further improved lung function. Both patients were discharged well.

1980 ◽  
Vol 239 (1) ◽  
pp. H96-H100
Author(s):  
R. E. Drake ◽  
J. C. Gabel

We estimated the pulmonary capillary membrane filtration coefficient (Kf) and the maximum capillary pressure (PCcritical) at which the lung could maintain a constant weight in 1) 5 control experiments in anesthetized open-chested dogs, 2) 7 experiments in which the dogs were given 3.6-8.3 microgram . kg-1 . min-1 of histamine phosphate, and 3) in 6 experiments after 75-100 mg/kg of alloxan. In additional experiments, pulmonary lymph flow (QL) and protein concentration (CL) were measured during the infusion of histamine and alloxan. After histamine, Kf averaged 0.045 +/- 0,008 ml . min-1mmHg-1 (SE) and PCcritical was 22.1 +/- 1.1 mmHg. These values were not significantly different from the control Kf and PCcritical (0.036 +/- 0.006 and 22.5 +/- 2.3, respectively). After alloxan, Kf (1.43 +/- 0.69) was larger and PCcritical (12.4 +/- 1.3) was significantly less than control (P less than 0.05). Histamine caused no significant change in QL or CL; however, both were increased after alloxan. These results show that Kf, PCcritical, QL, and CL are all changed by an increase in capillary membrane permeability caused by alloxan. Because none of these factors as significantly affected by histamine, dog lung capillary membrane permeability may not be affected by histamine.


Toxicon ◽  
1994 ◽  
Vol 32 (8) ◽  
pp. 999-1003 ◽  
Author(s):  
Carlos Faria Santos Amaral ◽  
Alfredo JoséAfonso Barbosa ◽  
Virginia Hora Rios Leite ◽  
Washington Luiz Tafuri ◽  
Nilton Alves de Rezende

2008 ◽  
Vol 139 (2_suppl) ◽  
pp. P196-P196 ◽  
Author(s):  
Lorraine M Smith ◽  
Ryan F Osborne

Problem To report the rare occurrence of a yolk sac tumor of the nose and nasopharynx presenting as acute sinusitis and bilateral complete blindness. Methods The clinical presentation, pathologic features, and management of this 2-year-old infant girl is reviewed. We also performed a medical literature search in English using PUBMED and OVID databases. We then analyzed the literature with respect to clinical presentation, manifestations and therapies for other extra-gonadal yolk sac tumors presenting in the head and neck. Results The patient was treated with 4 courses of high dose cis-platinum, etoposide, bleomycin repeated every 3 weeks along with surgery. She had initial mild improvement in visual perception along with shrinkage of her tumor. The yolk sac malignancies of the head and neck are often, large, aggressive lesions on presentation that once treated have a tendency to recur. Conclusion Yolk sac tumors (endodermal sinus tumors) represent 3–5% of pediatric malignancies. They are rare malignancies in the head and neck, of germ cell origin. Successful treatment usually requires a combination of chemotherapy and surgical extirpation followed by postoperative chemotherapy. Significance Recurrent sinusitis and nasal obstruction in children should be evaluated carefully and with a high level of suspicion for rare nasal and nasopharyngeal malignancies. Early diagnosis and prompt treatment may alleviate many of the presenting symptoms and prolong life.


The Lancet ◽  
1976 ◽  
Vol 307 (7957) ◽  
pp. 494 ◽  
Author(s):  
A. Harari ◽  
M. Rapin ◽  
B. Regnier ◽  
J. Comoy ◽  
J.P. Caron

Nutrients ◽  
2017 ◽  
Vol 9 (12) ◽  
pp. 1353 ◽  
Author(s):  
John Sluyter ◽  
Carlos Camargo ◽  
Debbie Waayer ◽  
Carlene Lawes ◽  
Les Toop ◽  
...  

Author(s):  
Cristiano Van Zeller ◽  
Asad Anwar ◽  
Nordita Ramos-Bascon ◽  
Natalie Barnes ◽  
Brendan Madden

COVID-19 ARDS has a high mortality and few therapeutic options. We present a preliminary report on our experience using high-dose pulsed methylprednisolone in COVID-19 ARDS and three-month outcomes. We performed a retrospective analysis of all patients treated with high-dose methylprednisolone for COVID-19 ARDS and three-month lung function, 6MWT, and CT findings. 15 patients were treated of which 10 survived to discharge. Reduced DLCO was the commonest abnormality in lung function tests and had the lowest mean value. Parenchymal bands were the commonest CT finding and 50% of patients had fibrosis at three-months. Mean 6MWD was 65.4% predicted and was abnormal in 62.5% of patients. In this cohort of patients with COVID-19 ARDS treated with high-dose methylprednisolone pulses, CT, lung function, and 6MWT abnormalities were unsurprisingly common at three months, although all 10 patients treated early in their disease course survived, a possible therapeutic effect. Further randomised controlled trials are needed to assess the benefits of this treatment.


2006 ◽  
Vol 31 (6) ◽  
pp. 759-760
Author(s):  
Alastair N.H. Hodges

Sub-clinical transient pulmonary oedema has been observed following exercise in both animals and, to some degree, humans. It has been proposed that transient pulmonary oedema, resulting from either pulmonary capillary leakage or capillary stress failure, may limit diffusion in the lung during and after exercise. Initially, to determine the minimal tolerable FIO2 for subsequent work in hypoxia, 10 aerobically trained males (VO2 max, 57.2 ± 7.95 mL·kg–1·min–1; age, 29.6 ± 5.8 y; height, 181.1 ± 8.3 cm; mass, 79.4 ± 5.6 kg) performed graded cycling work to maximal effort under 4 conditions of varying FIO2 (21%, 18%, 15%, and 12%) in a randomized blinded fashion. VO2 max and minimal SaO2 were significantly reduced while breathing 15% and 12% oxygen (VO2 max, 48.2 ± 7.9 and 31.5 ± 7.4 mL·kg–1·min–1, respectively). In the 12% oxygen condition, the majority of the subjects were not able to complete maximal exercise without SaO2 falling below 70%. Subsequently, to determine if transient pulmonary oedema occurs after sustained exercise, 10 highly trained male athletes (VO2 max, 65.0 ± 7.5 mL·kg–1·min–1; age, 25.9 ± 4.7 y; height, 184.1 ± 8.2 cm; mass, 79.4 ± 9.5 kg) underwent assessment of lung density by quantified magnetic resonance imaging before and 54.0 ± 17.2 and 100.7 ± 15.1 min after 60 min of cycling exercise (61.6% ± 9.5% VO2 max). The same 10 subjects underwent an identical measure before and 55.6 ± 9.8 and 104.3 ± 9.1 min after 60 min of cycling exercise (65.4% ± 7.1% hypoxic VO2 max) in hypoxia (FIO2 = 15.0%). Two subjects demonstrated mild exercise-induced arterial hypoxaemia (EIAH) (minSaO2 = 94.5% and 93.8%), and 7 demonstrated moderate EIAH (minSaO2 = 91.4% ± 1.1%) during a preliminary VO2 max test in normoxia. No significant differences (p < 0.05) were found in lung density after exercise in either condition. Mean lung densities, measured once pre- and twice post-exercise, were 0.177 ± 0.019, 0.181 ± 0.019, and 0.173 ± 0.019 g·mL–1 in the normoxic condition, and 0.178 ± 0.021, 0.174 ± 0.022, and 0.176 ± 0.019 g·mL–1 in the hypoxic condition. These results indicate that transient interstitial pulmonary oedema does not occur following sustained steady-state cycling exercise in normoxia or hypoxia. This diminishes the likelihood of pulmonary capillary leakage as a mechanism of transient pulmonary oedema, and, in turn, as a mechanism for changes in SaO2 during sustained exercise.


Author(s):  
Pedro L. Silva ◽  
Andreas Güldner ◽  
Christopher Uhlig ◽  
Nadja Cristinne S. Carvalho ◽  
Alessandro Beda ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document